Boston Scientific Corporation (BSX)
USD 104.93
(1.69%)
USD 104.93
(1.69%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 15.6 Billion USD | 4.77% |
| 2022 | 14.89 Billion USD | -4.56% |
| 2021 | 15.6 Billion USD | 1.01% |
| 2020 | 15.45 Billion USD | -7.41% |
| 2019 | 16.68 Billion USD | 35.97% |
| 2018 | 12.27 Billion USD | 2.02% |
| 2017 | 12.03 Billion USD | 5.87% |
| 2016 | 11.36 Billion USD | -3.81% |
| 2015 | 11.81 Billion USD | 18.28% |
| 2014 | 9.98 Billion USD | -2.04% |
| 2013 | 10.19 Billion USD | -0.87% |
| 2012 | 10.28 Billion USD | 3.49% |
| 2011 | 9.93 Billion USD | -8.26% |
| 2010 | 10.83 Billion USD | -15.87% |
| 2009 | 12.87 Billion USD | -7.65% |
| 2008 | 13.94 Billion USD | -13.4% |
| 2007 | 16.1 Billion USD | 1.91% |
| 2006 | 15.79 Billion USD | 303.63% |
| 2005 | 3.91 Billion USD | -5.57% |
| 2004 | 4.14 Billion USD | 46.11% |
| 2003 | 2.83 Billion USD | 43.07% |
| 2002 | 1.98 Billion USD | 1.23% |
| 2001 | 1.95 Billion USD | 31.3% |
| 2000 | 1.49 Billion USD | -19.26% |
| 1999 | 1.84 Billion USD | -39.84% |
| 1998 | 3.07 Billion USD | 212.92% |
| 1997 | 981.6 Million USD | 64.75% |
| 1996 | 595.8 Million USD | 85.03% |
| 1995 | 322 Million USD | 250.76% |
| 1994 | 91.8 Million USD | 20.0% |
| 1993 | 76.5 Million USD | 53.0% |
| 1992 | 50 Million USD | 6.16% |
| 1991 | 47.1 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 17.12 Billion USD | 3.78% |
| 2024 Q1 | 16.5 Billion USD | 5.73% |
| 2024 Q2 | 16.49 Billion USD | -0.02% |
| 2023 Q2 | 15.11 Billion USD | 2.25% |
| 2023 FY | 15.6 Billion USD | 4.77% |
| 2023 Q1 | 14.78 Billion USD | -0.76% |
| 2023 Q4 | 15.6 Billion USD | 4.64% |
| 2023 Q3 | 14.91 Billion USD | -1.34% |
| 2022 Q1 | 15.6 Billion USD | -0.03% |
| 2022 Q2 | 14.93 Billion USD | -4.26% |
| 2022 Q4 | 14.89 Billion USD | 4.12% |
| 2022 FY | 14.89 Billion USD | -4.56% |
| 2022 Q3 | 14.3 Billion USD | -4.22% |
| 2021 Q3 | 15.41 Billion USD | 1.24% |
| 2021 Q1 | 15.18 Billion USD | -1.75% |
| 2021 FY | 15.6 Billion USD | 1.01% |
| 2021 Q2 | 15.22 Billion USD | 0.3% |
| 2021 Q4 | 15.6 Billion USD | 1.25% |
| 2020 Q1 | 16.3 Billion USD | -2.27% |
| 2020 Q3 | 15.28 Billion USD | 0.49% |
| 2020 Q4 | 15.45 Billion USD | 1.11% |
| 2020 FY | 15.45 Billion USD | -7.41% |
| 2020 Q2 | 15.2 Billion USD | -6.76% |
| 2019 Q4 | 16.68 Billion USD | -2.16% |
| 2019 Q1 | 14.56 Billion USD | 18.71% |
| 2019 Q2 | 14.88 Billion USD | 2.16% |
| 2019 Q3 | 17.05 Billion USD | 14.6% |
| 2019 FY | 16.68 Billion USD | 35.97% |
| 2018 Q3 | 12.09 Billion USD | 1.84% |
| 2018 Q1 | 12.17 Billion USD | 1.18% |
| 2018 FY | 12.27 Billion USD | 2.02% |
| 2018 Q2 | 11.87 Billion USD | -2.47% |
| 2018 Q4 | 12.27 Billion USD | 1.51% |
| 2017 Q3 | 11.04 Billion USD | -0.89% |
| 2017 FY | 12.03 Billion USD | 5.87% |
| 2017 Q1 | 10.89 Billion USD | -4.16% |
| 2017 Q2 | 11.14 Billion USD | 2.36% |
| 2017 Q4 | 12.03 Billion USD | 8.89% |
| 2016 Q1 | 11.26 Billion USD | -4.67% |
| 2016 Q3 | 11.21 Billion USD | -3.47% |
| 2016 Q2 | 11.61 Billion USD | 3.17% |
| 2016 Q4 | 11.36 Billion USD | 1.32% |
| 2016 FY | 11.36 Billion USD | -3.81% |
| 2015 Q3 | 11.8 Billion USD | 11.97% |
| 2015 Q1 | 9.97 Billion USD | -0.16% |
| 2015 FY | 11.81 Billion USD | 18.28% |
| 2015 Q4 | 11.81 Billion USD | 0.07% |
| 2015 Q2 | 10.54 Billion USD | 5.74% |
| 2014 Q1 | 9.8 Billion USD | -3.86% |
| 2014 FY | 9.98 Billion USD | -2.04% |
| 2014 Q3 | 10.01 Billion USD | 0.85% |
| 2014 Q2 | 9.93 Billion USD | 1.35% |
| 2014 Q4 | 9.98 Billion USD | -0.3% |
| 2013 Q2 | 10.39 Billion USD | 1.3% |
| 2013 Q1 | 10.26 Billion USD | -0.23% |
| 2013 FY | 10.19 Billion USD | -0.87% |
| 2013 Q4 | 10.19 Billion USD | -1.54% |
| 2013 Q3 | 10.35 Billion USD | -0.38% |
| 2012 Q1 | 9.78 Billion USD | -1.49% |
| 2012 Q2 | 10.09 Billion USD | 3.1% |
| 2012 Q3 | 10.07 Billion USD | -0.22% |
| 2012 Q4 | 10.28 Billion USD | 2.13% |
| 2012 FY | 10.28 Billion USD | 3.49% |
| 2011 Q2 | 10.01 Billion USD | -6.37% |
| 2011 Q1 | 10.7 Billion USD | -1.21% |
| 2011 Q3 | 9.98 Billion USD | -0.38% |
| 2011 Q4 | 9.93 Billion USD | -0.44% |
| 2011 FY | 9.93 Billion USD | -8.26% |
| 2010 Q2 | 12.12 Billion USD | 0.45% |
| 2010 Q4 | 10.83 Billion USD | -5.38% |
| 2010 Q3 | 11.44 Billion USD | -5.59% |
| 2010 FY | 10.83 Billion USD | -15.87% |
| 2010 Q1 | 12.07 Billion USD | -6.24% |
| 2009 FY | 12.87 Billion USD | -7.65% |
| 2009 Q4 | 12.87 Billion USD | 1.88% |
| 2009 Q3 | 12.63 Billion USD | -1.1% |
| 2009 Q2 | 12.77 Billion USD | -0.39% |
| 2009 Q1 | 12.82 Billion USD | -8.13% |
| 2008 Q3 | 14.13 Billion USD | -0.91% |
| 2008 Q1 | 14.95 Billion USD | -7.11% |
| 2008 FY | 13.94 Billion USD | -13.4% |
| 2008 Q4 | 13.96 Billion USD | -1.21% |
| 2008 Q2 | 14.26 Billion USD | -4.61% |
| 2007 Q3 | 15.81 Billion USD | 2.29% |
| 2007 FY | 16.1 Billion USD | 1.91% |
| 2007 Q1 | 15.52 Billion USD | -1.76% |
| 2007 Q2 | 15.46 Billion USD | -0.37% |
| 2007 Q4 | 16.1 Billion USD | 1.79% |
| 2006 Q4 | 15.79 Billion USD | 0.39% |
| 2006 Q1 | 4.43 Billion USD | 13.39% |
| 2006 FY | 15.79 Billion USD | 303.63% |
| 2006 Q2 | 15.72 Billion USD | 254.33% |
| 2006 Q3 | 15.73 Billion USD | 0.07% |
| 2005 FY | 3.91 Billion USD | -5.57% |
| 2005 Q1 | 3.42 Billion USD | -17.27% |
| 2005 Q2 | 3.86 Billion USD | 12.74% |
| 2005 Q3 | 4.17 Billion USD | 7.99% |
| 2005 Q4 | 3.91 Billion USD | -6.25% |
| 2004 Q3 | 3.97 Billion USD | 6.71% |
| 2004 Q2 | 3.72 Billion USD | 42.02% |
| 2004 Q4 | 4.14 Billion USD | 4.2% |
| 2004 Q1 | 2.62 Billion USD | -7.47% |
| 2004 FY | 4.14 Billion USD | 46.11% |
| 2003 Q2 | 2.26 Billion USD | 6.18% |
| 2003 Q3 | 2.62 Billion USD | 15.82% |
| 2003 Q4 | 2.83 Billion USD | 7.95% |
| 2003 FY | 2.83 Billion USD | 43.07% |
| 2003 Q1 | 2.13 Billion USD | 7.77% |
| 2002 Q3 | 1.98 Billion USD | -1.93% |
| 2002 Q4 | 1.98 Billion USD | 0.1% |
| 2002 FY | 1.98 Billion USD | 1.23% |
| 2002 Q1 | 1.91 Billion USD | -2.35% |
| 2002 Q2 | 2.02 Billion USD | 5.59% |
| 2001 FY | 1.95 Billion USD | 31.3% |
| 2001 Q2 | 1.79 Billion USD | 14.64% |
| 2001 Q4 | 1.95 Billion USD | 3.11% |
| 2001 Q3 | 1.9 Billion USD | 5.97% |
| 2001 Q1 | 1.56 Billion USD | 4.83% |
| 2000 FY | 1.49 Billion USD | -19.26% |
| 2000 Q1 | 1.73 Billion USD | -6.17% |
| 2000 Q4 | 1.49 Billion USD | 0.88% |
| 2000 Q2 | 1.61 Billion USD | -6.86% |
| 2000 Q3 | 1.47 Billion USD | -8.42% |
| 1999 Q2 | 2.08 Billion USD | -29.34% |
| 1999 Q1 | 2.95 Billion USD | -3.8% |
| 1999 FY | 1.84 Billion USD | -39.84% |
| 1999 Q3 | 1.88 Billion USD | -9.67% |
| 1999 Q4 | 1.84 Billion USD | -2.01% |
| 1998 Q1 | 1.06 Billion USD | 8.32% |
| 1998 FY | 3.07 Billion USD | 212.92% |
| 1998 Q3 | 3.26 Billion USD | 212.25% |
| 1998 Q4 | 3.07 Billion USD | -6.04% |
| 1998 Q2 | 1.04 Billion USD | -1.54% |
| 1997 FY | 981.6 Million USD | 64.75% |
| 1997 Q1 | 589 Million USD | -1.14% |
| 1997 Q2 | 792.5 Million USD | 34.55% |
| 1997 Q3 | 836.1 Million USD | 5.5% |
| 1997 Q4 | 981.6 Million USD | 17.4% |
| 1996 Q4 | 595.8 Million USD | 13.25% |
| 1996 Q3 | 526.1 Million USD | 3.75% |
| 1996 Q2 | 507.1 Million USD | 13.67% |
| 1996 FY | 595.8 Million USD | 85.03% |
| 1996 Q1 | 446.1 Million USD | 38.54% |
| 1995 Q1 | 343.8 Million USD | 274.51% |
| 1995 Q2 | 305.5 Million USD | -11.14% |
| 1995 Q3 | 188.5 Million USD | -38.3% |
| 1995 Q4 | 322 Million USD | 70.82% |
| 1995 FY | 322 Million USD | 250.76% |
| 1994 Q1 | 77.3 Million USD | 1.05% |
| 1994 Q3 | 80.3 Million USD | 5.38% |
| 1994 Q2 | 76.2 Million USD | -1.42% |
| 1994 Q4 | 91.8 Million USD | 14.32% |
| 1994 FY | 91.8 Million USD | 20.0% |
| 1993 FY | 76.5 Million USD | 53.0% |
| 1993 Q4 | 76.5 Million USD | -9.68% |
| 1993 Q1 | 56 Million USD | 12.0% |
| 1993 Q2 | 72.4 Million USD | 29.29% |
| 1993 Q3 | 84.7 Million USD | 16.99% |
| 1992 Q1 | 68.6 Million USD | 45.65% |
| 1992 FY | 50 Million USD | 6.16% |
| 1992 Q3 | 52.9 Million USD | 5.59% |
| 1992 Q2 | 50.1 Million USD | -26.97% |
| 1992 Q4 | 50 Million USD | -5.48% |
| 1991 FY | 47.1 Million USD | 0.0% |
| 1991 Q4 | 47.1 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Abbott Laboratories | 34.38 Billion USD | 54.617% |
| Allurion Technologies Inc. | 142.19 Million USD | -10874.761% |
| Artivion, Inc. | 510.61 Million USD | -2956.302% |
| Avanos Medical, Inc. | 456.1 Million USD | -3321.618% |
| Butterfly Network, Inc. | 84.22 Million USD | -18429.82% |
| Butterfly Network, Inc. | 84.22 Million USD | -18429.82% |
| Bio-Rad Laboratories, Inc. | 3.55 Billion USD | -338.625% |
| CONMED Corporation | 1.46 Billion USD | -964.675% |
| Edwards Lifesciences Corporation | 2.64 Billion USD | -490.287% |
| Paragon 28, Inc. | 162.95 Million USD | -9476.701% |
| Glaukos Corporation | 478.64 Million USD | -3160.434% |
| Globus Medical, Inc. | 1.08 Billion USD | -1334.212% |
| Inspire Medical Systems, Inc. | 104.29 Million USD | -14863.038% |
| Integer Holdings Corporation | 1.41 Billion USD | -1004.284% |
| Medtronic plc | 39.56 Billion USD | 60.552% |
| Myomo, Inc. | 5.59 Million USD | -278966.374% |
| Nevro Corp. | 330.31 Million USD | -4624.638% |
| Owlet, Inc. | 73.79 Million USD | -21046.628% |
| Penumbra, Inc. | 377.36 Million USD | -4035.562% |
| Vicarious Surgical Inc. | 21.89 Million USD | -71176.547% |
| Smith & Nephew plc | 4.77 Billion USD | -227.17% |
| STERIS plc | 4.74 Billion USD | -228.661% |
| Stryker Corporation | 21.31 Billion USD | 26.798% |
| Vapotherm, Inc. | 132.95 Million USD | -11638.159% |
| Zimmer Biomet Holdings, Inc. | 9 Billion USD | -73.233% |